Molina Healthcare (MOH)
(Delayed Data from NYSE)
$325.43 USD
-4.87 (-1.47%)
Updated Oct 10, 2024 04:00 PM ET
After-Market: $325.43 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value F Growth D Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$325.43 USD
-4.87 (-1.47%)
Updated Oct 10, 2024 04:00 PM ET
After-Market: $325.43 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value F Growth D Momentum D VGM
Zacks News
Magellan (MGLN) Q1 Earnings Top on Lower Medical Utilization
by Zacks Equity Research
Magellan Health's (MGLN) Q1 earnings benefit from higher profit owing to lower utilization of elective procedures.
Has Molina Healthcare (MOH) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (MOH) Outperforming Other Medical Stocks This Year?
Should Value Investors Buy Molina (MOH) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Will Molina Healthcare Continue to Surge Higher?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor Molina Healthcare
Molina Healthcare (MOH) Q1 Earnings Miss Mark, Slip Y/Y
by Zacks Equity Research
Molina Healthcare's (MOH) Q1 results reflect high expenses and low net income.
Molina (MOH) Lags Q1 Earnings Estimates
by Zacks Equity Research
Molina (MOH) delivered earnings and revenue surprises of -0.33% and 2.74%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Is a Surprise Coming for Molina Healthcare (MOH) This Earnings Season?
by Zacks Equity Research
Molina Healthcare (MOH) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Centene's (CNC) Q1 Earnings Miss Estimates, Decline Y/Y
by Zacks Equity Research
Centene's (CNC) Q1 results reflect muted earnings due to lower investment income and incremental senior note interest expense.
Will Membership Growth Drive Cigna's (CI) Earnings in Q1?
by Zacks Equity Research
Cigna's (CI) Q1 earnings are likely to have been aided by revenue growth in various segments.
Molina Healthcare's (MOH) Q1 Earnings: What's in Store?
by Zacks Equity Research
Molina Healthcare's (MOH) first-quarter results are likely to reflect lower membership, partly offset by better revenues.
What's in the Cards for Anthem's (ANTM) Earnings in Q1?
by Zacks Equity Research
Anthem's (ANTM) Q1 earnings results are likely to reflect higher revenues, backed by its Government and Commercial & Specialty businesses.
Humana (HUM) Gears up for Earnings in Q1: What to Expect
by Zacks Equity Research
Humana's (HUM) Q1 earnings results are likely to reflect growth in revenues, which in turn, are expected to have been driven by its Medicaid and Medicare businesses.
Molina (MOH) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
by Zacks Equity Research
Molina (MOH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
What's in the Cards for Centene's (CNC) Earnings in Q1?
by Zacks Equity Research
Centene's (CNC) Q1 results are likely to reflect escalating expenses, partially offset by higher revenues.
HMO Industry: Bullish Near-Term Outlook Despite Coronavirus Impact
by Sapna Bagaria
Health Insurers are likely to gain from higher demand for its products and services from senior citizens and the rising incidence of illness, partially offset by the COVID-19-led fallout.
HCA Healthcare (HCA) to Report Q1 Earnings: What's in Store?
by Zacks Equity Research
HCA Healthcare's (HCA) Q1 results are likely to reflect weak volumes from the coronavirus effect.
Molina Healthcare Gains on Sanders' Exit From Presidential Race
by Zacks Equity Research
Molina Healthcare (MOH) gains from Bernie Sanders' withdrawal from the presidential campaign.
UnitedHeath (UNH) Beats on Q1 Earnings, Dodges Coronavirus Curse
by Zacks Equity Research
UnitedHealth's (UNH) Q1 earnings benefit from higher contribution at both its segments, escaping the fallout from the coronavirus-led crisis.
Molina (MOH) is a Great Momentum Stock: Should You Buy?
by Zacks Equity Research
Does Molina (MOH) have what it takes to be a top stock pick for momentum investors? Let's find out.
The Zacks Analyst Blog Highlights: Centene, Anthem, Humana, Molina Healthcare and Magellan Health
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Centene, Anthem, Humana, Molina Healthcare and Magellan Health
The Zacks Analyst Blog Highlights: Molina Healthcare, Cigna, UnitedHealth, Anthem and Humana
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Molina Healthcare, Cigna, UnitedHealth, Anthem and Humana
7 Health Insurers Poised to Beat Earnings Estimates in Q1
by Zacks Equity Research
Health insurers are likely to gain from a solid revenue base, attributable to higher premiums across Medicare, Medicaid plans.
Centene Soars 47.8% in Six Months: Will the Rally Continue?
by Zacks Equity Research
Centene's (CNC) strategic initiatives and higher membership might aid its revenues to perk up its share price in turn.
Is Molina Healthcare (MOH) Stock a Solid Choice Right Now?
by Zacks Equity Research
Molina Healthcare (MOH) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Sanders Gives Health Insurers a Boost: Spotlight on 5 Stocks
by Tirthankar Chakraborty
Sanders' policies haven't been positive for health insurance stocks. He has favored Medicare-For-All and intended to abolish private insurance, which had cast a shadow on health insurance companies for months.